Journal of Cancer Metastasis and Treatment
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Journal of Cancer Metastasis and Treatment
Search Submit
Home Articles Special Issues Volumes Webinars Videos

fig1

From:  ImmuneScore as a novel RNA-based prognostic signature superior to PD-L1 in advanced non-squamous NSCLC patients receiving chemotherapy combined with immune checkpoint inhibitor therapy
ImmuneScore as a novel RNA-based prognostic signature superior to PD-L1 in advanced non-squamous NSCLC patients receiving chemotherapy combined with immune checkpoint inhibitor therapy

Figure 1. CONSORT flow diagram of the included patients. ICI: Immune checkpoint inhibitor.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/journal-cancer-metastasis-and-treatment

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/journal-cancer-metastasis-and-treatment

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2025 OAE Publishing Inc., except certain content provided by third parties